The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer

S. B. Bull, H. Ozcelik, D. Pinnaduwage, M. E. Blackstein, T. C. Hurd

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer'. Together they form a unique fingerprint.